Traws Pharma (TRAW) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cencora says Walgreens volumes shift, reaffirms guidance, shares sink
- Goldman Sachs expects July core PCE to rise 0.23%
- Barclays sees upside for Alibaba, Churchill Downs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
